This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Philip Morris' Q4 Earnings on Deck: Key Factors to Understand
by Zacks Equity Research
PM's Q4 results are likely to reflect gains from pricing and smoke-free strength amid volatile currency movements.
Gear Up for Kenvue (KVUE) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Kenvue (KVUE) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Kellanova Set to Release Q4 Earnings: Should You Expect a Beat?
by Zacks Equity Research
K's fourth-quarter results are likely to reflect gains from strategic pricing actions and cost-saving efforts.
Post Holdings' Q1 Earnings on Deck: Key Factors to Understand
by Zacks Equity Research
POST's Q1 results are likely to reflect strength in the Foodservice segment while showing concerns related to escalated advertising costs.
Analysts Estimate Newell Brands (NWL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Newell Brands (NWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kenvue (KVUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Kenvue (KVUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Mondelez Gears Up for Q4 Earnings: Here's What You Should Know
by Zacks Equity Research
MDLZ's fourth-quarter results are likely to reflect strength in core categories, while cocoa cost inflation is a concern.
EL Gears Up for Upcoming Q2 Earnings: Here's What You Should Know
by Zacks Equity Research
The Estee Lauder Companies' fiscal second-quarter results are likely to reflect the adverse impact of weakness across China and Asia travel retail.
Is Tyson Foods Up for an Earnings Beat in Its Q1 Earnings Release?
by Zacks Equity Research
TSN's Q1 results are likely to reflect gains from its chicken and prepared foods segments despite facing volume-related issues in the beef sector.
Is Church & Dwight Up for an Earnings Beat in Its Q4 Release?
by Zacks Equity Research
CHD's Q4 results are likely to reflect gains from brand strength and pricing power in a dynamic consumer environment.
How to Play J&J Stock After Q4 Beat & Soft 2025 Sales Guidance
by Kinjel Shah
Those who own JNJ stock may stay invested for some time as the company looks optimistic about a better performance in 2025.
4 Consumer Staple Stocks Likely to Top Earnings Estimates This Season
by Vrishali Bagree
Companies with solid brands and efficient cost-management efforts are poised to shine amid a dynamic consumer landscape. KMB, CHD, CLX and KVUE are in focus.
J&J's Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance
by Zacks Equity Research
JNJ beats estimates for fourth-quarter earnings and sales. Its sales guidance for 2025 falls short of expectations.
Procter & Gamble (PG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 1.08% and 1.33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Earnings?
by Zacks Equity Research
JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. It remains to be seen if MedTech sales improved.
Will Kenvue (KVUE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Kenvue (KVUE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
J&J Trading Near 52-Week Low: Should You Sell the Stock?
by Kinjel Shah
Those who own the stock may stay invested for some time as J&J looks optimistic about a better performance in 2025.
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPYD
Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SDY
J&J Loses Around $24B in a Month: How to Play the Stock?
by Kinjel Shah
The decline in J&J's share price and the drug/biotech sector's downturn in the past month have left investors wondering if they should sell J&J stock.
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYD
Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SDY
Here's What Key Metrics Tell Us About Kenvue (KVUE) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for Kenvue (KVUE) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.